Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

South Africa

SAHPRA registration is followed by distinct public and private routes. Public access uses STGs/EML, national tenders and facility delivery; private access uses SEP, scheme benefits/PMBs, formularies, networks and authorisation.

SAHPRA / local applicant
NDoH PEE / company / payer/purchaser
EDP ERCs / NEMLC
NDoH/province/facility / supplier
medical scheme / treating clinician
8 decision nodes18 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it